Wave Life Sciences rose more than 23% in premarket trading; the company is developing an RNA drug candidate targeting the INHBE gene. Arrowhead rose more than 13%; the company’s gene-silencing drug demonstrated fat-reducing effects in early-stage clinical trials for obesity.

Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.